4.7 Article

Clinical outcomes of COVID-19 infection among patients with Alzheimer's disease or mild cognitive impairment

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cell & Tissue Engineering

ApoE-Isoform-Dependent SARS-CoV-2 Neurotropism and Cellular Response

Cheng Wang et al.

Summary: The study suggests a potential causal role of ApoE4 in the severity of COVID-19, as tested in human-induced pluripotent stem cell (hiPSC) models for SARS-CoV-2 neurotropism. Increased infection rates of SARS-CoV-2 in ApoE4/4 neurons and astrocytes were observed, with changes in ApoE4 astrocytes upon infection. Remdesivir treatment was effective in inhibiting SARS-CoV2 infection in hiPSC neurons and astrocytes, highlighting the impact of risk factors on COVID-19 severity.

CELL STEM CELL (2021)

Article Geriatrics & Gerontology

Alzheimer's and Parkinson's Diseases Predict Different COVID-19 Outcomes: A UK Biobank Study

Yizhou Yu et al.

Summary: In December 2019, the COVID-19 pandemic began, resulting in over 45,000 deaths in the UK. Research indicates that elderly individuals with Alzheimer's disease face the highest risk of COVID-19 and mortality, while Parkinson's disease patients have a higher risk of SARS-CoV-2 infection.

GERIATRICS (2021)

Article Neurosciences

SARS-CoV-2 Infection in the Central and Peripheral Nervous System-Associated Morbidities and Their Potential Mechanism

Mohan Kumar Muthu Karuppan et al.

Summary: The recent outbreak of COVID-19 caused by SARS-CoV-2 is a defining global health crisis, with evidence suggesting neurological issues may arise from the virus invading the CNS and PNS. The most critical symptom seems to be sudden loss of breathing in some patients, indicating potential dysfunction in brainstem regulatory centers. Further research is needed to confirm the virus's role in neurodegeneration.

MOLECULAR NEUROBIOLOGY (2021)

Editorial Material Clinical Neurology

The effects of the COVID-19 pandemic on people with dementia

Katya Numbers et al.

Summary: People with dementia are at high risk of SARS-CoV-2 infection due to cognitive symptoms and living arrangements in care homes. Once infected, they are more likely to experience severe outcomes and death. Certain genotype may increase the risk of COVID-19 hospitalization, and dementia in older adults, especially those in care homes, can lead to worsening psychiatric symptoms and severe behavioral disturbances during the pandemic.

NATURE REVIEWS NEUROLOGY (2021)

Article Clinical Neurology

The Spatial and Cell-Type Distribution of SARS-CoV-2 Receptor ACE2 in the Human and Mouse Brains

Rongrong Chen et al.

Summary: The distribution of ACE2 in human and mouse brains differs, which may play a crucial role in central nervous system symptoms in COVID-19 patients infected with SARS-CoV-2. Potential species differences should be taken into consideration when using mouse models to study the neurological effects of SARS-CoV-2 infection.

FRONTIERS IN NEUROLOGY (2021)

Article Clinical Neurology

COVID-19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US

QuanQiu Wang et al.

Summary: Patients with dementia are at increased risk for COVID-19 compared to those without dementia, with vascular dementia carrying the highest risk. Black patients with dementia have a higher risk of COVID-19 compared to White patients.

ALZHEIMERS & DEMENTIA (2021)

Article Biochemistry & Molecular Biology

Attributes and predictors of long COVID

Carole H. Sudre et al.

Summary: Reports on long-lasting COVID-19 symptoms, known as 'long COVID', are increasing. Analysis of data from over 4,000 COVID-19 cases revealed that long COVID is more common in older individuals, those with higher body mass index, and females. Experiencing more than five symptoms in the first week of illness was associated with long COVID. A simple model showed promise in distinguishing between short and long COVID cases early in the disease.

NATURE MEDICINE (2021)

Review Neurosciences

COVID-19 and Alzheimer's Disease

Marcello Ciaccio et al.

Summary: SARS-CoV-2 can cause neurological symptoms, potentially affecting the nervous system and increasing the risk of developing neurodegenerative diseases, with a mutualistic relationship found with Alzheimer's Disease.

BRAIN SCIENCES (2021)

Article Multidisciplinary Sciences

The association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension

Mingfei Li et al.

Summary: The study aimed to investigate the association between ACEI and ARB medication use and COVID-19 occurrence and severity in US Veterans with hypertension. Results showed that ACEI significantly decreased the odds of testing positive for COVID-19 and was associated with a slight increase in the odds of using mechanical ventilators.

PLOS ONE (2021)

Editorial Material Clinical Neurology

Severe COVID-19 in Alzheimer's disease: APOE4's fault again?

Nian Xiong et al.

Summary: Challenges have been recognized in healthcare for patients with Alzheimer's disease (AD) during the COVID-19 pandemic, with a focus on the APOE4 gene and its potential association with increased infection risk and severity in these patients.

ALZHEIMERS RESEARCH & THERAPY (2021)

Article Medicine, General & Internal

Characterizing long COVID in an international cohort: 7 months of symptoms and their impact

Hannah E. Davis et al.

Summary: Patients with Long COVID report prolonged, multisystem involvement and significant disability. By seven months, many patients have not yet recovered (mainly from systemic and neurological/cognitive symptoms), have not returned to previous levels of work, and continue to experience significant symptom burden.

ECLINICALMEDICINE (2021)

Article Geriatrics & Gerontology

Anticipating and Mitigating the Impact of the COVID-19 Pandemic on Alzheimer's Disease and Related Dementias

Eric E. Brown et al.

AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2020)

Letter Immunology

SARS-CoV-2: A new virus but a familiar inflammation brain pattern

Giuseppe De Santis

BRAIN BEHAVIOR AND IMMUNITY (2020)

Editorial Material Medicine, General & Internal

Covid-19: risk factors for severe disease and death

Rachel E. Jordan et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Article Medicine, General & Internal

Multiorgan and Renal Tropism of SARS-CoV-2

Victor G. Puelles et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Letter Geriatrics & Gerontology

ApoE e4e4 Genotype and Mortality With COVID-19 in UK Biobank

Chia-Ling Kuo et al.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2020)

Review Neurosciences

COVID-19: Review of a 21st Century Pandemic from Etiology to Neuro-psychiatric Implications

Vicky Yamamoto et al.

JOURNAL OF ALZHEIMERS DISEASE (2020)

Article Neurosciences

The Impact of Dementia on the Clinical Outcome of COVID-19: A Systematic Review and Meta-Analysis

Nanyang Liu et al.

JOURNAL OF ALZHEIMERS DISEASE (2020)

Article Geriatrics & Gerontology

The effects of cerebral amyloid angiopathy on integrity of the blood-brain barrier

Shino Magaki et al.

NEUROBIOLOGY OF AGING (2018)

Review Neurosciences

The blood-brain barrier in Alzheimer's disease

Elena Zenaro et al.

NEUROBIOLOGY OF DISEASE (2017)

Review Neurosciences

The Infectious Etiology of Alzheimer's Disease

Marta Sochocka et al.

CURRENT NEUROPHARMACOLOGY (2017)

Article Medicine, General & Internal

Do clinicians understand the size of treatment effects? A randomized survey across 8 countries

Bradley C. Johnston et al.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2016)

Article Geriatrics & Gerontology

Herpes simplex virus type 2 infection induces AD-like neurodegeneration markers in human neuroblastoma cells

Henrike Kristen et al.

NEUROBIOLOGY OF AGING (2015)

Article Neurosciences

Blood-Brain Barrier Breakdown in the Aging Human Hippocampus

Axel Montagne et al.

NEURON (2015)

Article Multidisciplinary Sciences

Different Brain Regions are Infected with Fungi in Alzheimer's Disease

Diana Pisa et al.

SCIENTIFIC REPORTS (2015)

Article Neurosciences

Link Between Chronic Bacterial Inflammation and Alzheimer Disease

Fehmida Bibi et al.

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2014)

Article Public, Environmental & Occupational Health

Can Infections Cause Alzheimer's Disease?

Francis Ellawanda et al.

EPIDEMIOLOGIC REVIEWS (2013)

Article Statistics & Probability

How Big is a Big Odds Ratio? Interpreting the Magnitudes of Odds Ratios in Epidemiological Studies

Henian Chen et al.

COMMUNICATIONS IN STATISTICS-SIMULATION AND COMPUTATION (2010)

Article Clinical Neurology

Herpesviruses in brains in Alzheimer's and Parkinson's diseases

N Hemling et al.

ANNALS OF NEUROLOGY (2003)